Recall Atlas
Drugs & medicalType II

Esomeprazole, Candesartan and Pravastatin Tablets: OOS result for Finished Product Assay and/or Blend Uniformity

Product quality

Read the official notice →
Date
2022-09-21
Country
Canada
Product
TARO-ESOMEPRAZOLE 20MG, TARO-ESOMEPRAZOLE 40MG, TARO-CANDESARTAN, TARO-PRAVASTATIN
Classification
Type II
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2022-09-23
  2. CA
    Drugs & medicalType II

    Respironics Masks

    Labelling and packaging

    Health CanadaOfficial notice →
  3. 2022-09-22
  4. CA
    Drugs & medicalType II

    Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406

    Labelling

    Health CanadaOfficial notice →
  5. 2022-09-21
  6. CA
    Drugs & medicalType II

    Venlafaxine: OOS result for Spheroids Dissolution Rate Profile (DRP)

    Product quality

    Health CanadaOfficial notice →
  7. 2022-09-20
  8. CA
    Drugs & medicalType II

    Flexible Cystoscope

    Sterility

    Health CanadaOfficial notice →
  9. CA
    Drugs & medicalType II

    Smallbore T-Port Extension Set

    Performance

    Health CanadaOfficial notice →
  10. CA
    Drugs & medicalType II

    Xpert EV Assay

    Performance

    Health CanadaOfficial notice →
See all drugs & medical recalls →